Production of lymphocyte activating factor in the absence of endogenous pyrogen by rabbit or human leukocytes stimulated by a muramyl dipeptide derivative
- 1 January 1982
- journal article
- research article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 4 (5), 451-462
- https://doi.org/10.1016/0192-0561(82)90020-0
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Components of mycobacteria and muramyl dipeptide with adjuvant activity induce lymphocyte activating factorCellular Immunology, 1980
- Bacterial Endotoxins and Host Immune ResponsesAdvances in Immunology, 1980
- Revised nomenclature for antigen-nonspecific T-cell proliferation and helper factorsCellular Immunology, 1979
- Enhancement by Muramyl Dipeptide ofin vitroNude Mice Responses to a T-Dependent AntigenImmunological Communications, 1979
- Pathogenesis of Fever in ManNew England Journal of Medicine, 1978
- SYNTHESIS OF N‐ACETYL‐MURAMYL‐L‐ALANYL‐D‐ISOGLUTAMINE, AN ADJUVANT OF THE IMMUNE RESPONSE, AND OF SOME N‐ACETYL‐MURAMYL‐PEPTIDE ANALOGSInternational Journal of Peptide and Protein Research, 1977
- Correlation of structure and adjuvant activity of N-acetyl muramyl-L-alanyl-D-isoglutamine (MDP), its derivatives and analogues. Anti-adjuvant and competition properties of stereoisomersBiochemical and Biophysical Research Communications, 1976
- Distinctive adjuvanticity of synthetic analogs of mycobacterial water-soluble componentsCellular Immunology, 1976
- Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivativesBiochemical and Biophysical Research Communications, 1974
- SPECIES SPECIFICITY OF LEUKOCYTIC PYROGENSThe Journal of Experimental Medicine, 1969